138 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
of those arrangements do not encourage unnecessary risk-taking;
overseeing any major changes in employee benefits structures throughout the company … as a member of our board of directors in 2023. Dr. Scots-Knight’s compensation for service as an employee for fiscal years 2023 and 2022 is presented
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
and are vulnerable to breakdown, breach, interruption or damage from cyber incidents, employee error or malfeasance, misconfigurations, “bugs” or other … access to employee accounts using stolen or inferred credentials, computer malware (e.g. ransomware), viruses, spamming, social engineering
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, if such acquisition or disposal occurs on a regulated market. A director, officer or other employee, agent, consultant, or any other advisor, such as accountants … Act of 1933).
Any employee who is uncertain whether these or other prohibitions or restrictions apply should ask the General Counsel before engaging
S-8
MREO
Mereo Biopharma Group Plc
23 Jan 24
Registration of securities for employees
4:16pm
, as amended on February 13, 2020 and January 15, 2021, and the Mereo BioPharma Group plc 2019 Non-Employee Equity Incentive Plan, as amended on February 13
S-8
MREO
Mereo Biopharma Group Plc
23 Jan 24
Registration of securities for employees
4:16pm
BioPharma Group plc 2019 Equity Incentive Plan, as amended
Mereo BioPharma Group plc 2019 Non-Employee Equity Incentive Plan, as amended
(Full title … Group plc 2019 Non-Employee Equity Incentive Plan, as amended on February 13, 2020 and January 15, 2021 (collectively, the “Plans”). In accordance
S-8
EX-4.3
swgurz 4d5
23 Jan 24
Registration of securities for employees
4:16pm
S-8
EX-5.1
83iy0
23 Jan 24
Registration of securities for employees
4:16pm
6-K
EX-99.2
jp9lor3foq61m4
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.1
gdeco9 hvvp507
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.3
h8f51
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
dcwkpzukl98ajlu812n0
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
rw14mn
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
epefyx
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.2
vwz7au8vb27yhg
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
e60vkgj
18 Oct 22
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
7:07am
6-K
7qbp2g0xh
26 May 22
Current report (foreign)
4:11pm
6-K
408gze9p12 uq
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am